University of Hawaii
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Hawaii sits in the top decile of US sponsors by registered trial count (#284 of 15,742 sponsors by registered trial count).
University of Hawaii: 77 sponsored US clinical trials, 13 recruiting.
University of Hawaii sponsors 77 registered US clinical trials on ClinicalTrials.gov, 13 of them currently recruiting, and 51 completed. 4 of these trials are in Phase 3-4 (later-stage) and 14 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Type 2 Diabetes, with 4 trials.
Top-decile sponsor footprint
University of Hawaii ranks in the top decile of sponsors by registered trial count (#284 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
51 of 56 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (91.1%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
77 total, page 2 of 2
Effect of Cenicriviroc on HIV Neurocognitive Impairment
NCT02128828
Partners in Care With Semi-Structured Support Group
NCT02144909
Hula, a Physical Activity Intervention for Female-Cancer Survivors
NCT02351479
Partnerships to Improve Lifestyle Interventions (PILI) 'Ohana Dissemination Project
NCT02320331
Partnerships to Improve Lifestyle Interventions (PILI) 'Ohana Dissemination Project Partners in Care
NCT02320344
A Home Exercise Program for Women With Infants & Young Children
NCT01738984
Children's Healthy Living Community Randomized Trial
NCT01881373
Glycemic Response to High Amylose Rice
NCT01685879
Ola Hou i ka Hula: Hula and Hypertension
NCT01995812
Use Of The Dietary Supplement 5-ALA And Its Relationship With Sleep And Mood
NCT01508741
Oral Contraceptives and Subantimicrobial Doxycycline: Effect on Endometrial Matrix Metalloproteinases
NCT01469585
Ferumoxytol-enhanced Brain MRI in HIV-associated Neurocognitive Disorders
NCT01665846
PILI at Work a 5-Year Controlled Intervention Trial: Testing DVD Versus Group Delivery of a Weight-Loss Maintenance Intervention in Native Hawaiian- Serving Worksites
NCT01652989
Testing Different Theories of Smoking Cessation: An Intervention Study
NCT01209897
Maraviroc Intensification and Peripheral Blood Monocyte HIV DNA Levels
NCT00987948
Partners in Care Diabetes Self-management Intervention
NCT01235429
Partnerships to Overcome Obesity Disparities in Hawaii: 18-month CBPR Study
NCT01093924
Effect of Rosuvastatin on Endothelial Function
NCT00986999
Physical Activity in Women With Infants
NCT00810342
Intervention to Motivate Teens to be a Designated Organ Donor on Driver's License
NCT00810901
Blood Loss at the Time of First Trimester Surgical Abortion in Anticoagulated Women
NCT00614432
Study of Niacin on Endothelial Function in HIV-infected Subjects With Low High Density Lipoprotein Cholesterol Levels
NCT00986986
Is Monitoring Activity Important for Short- and Long-term Weight Loss?
NCT00544245
PILI 'Ohana Project: Partnerships to Overcome Obesity Disparities in Hawaii (3-Year Pilot)
NCT01042886
Goal Setting and Lifestyle
NCT01110213
Partnership Programs for Reducing Cardiovascular Disparities in Native Hawaiians
NCT00101465
Cognitive Behavioral Intervention in Diabetes Self-Management
NCT01182701
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 3 |
| Phase 2 | 11 |
| Phase 3 | 2 |
| Phase 4 | 2 |
What is open in the University of Hawaii pipeline
13 recruiting of 77 indexed (17% open); 51 completed (66%).
Phase mix: 4 late (III/IV) vs 14 early (I/II) (early-phase heavy).
Top condition: Type 2 Diabetes (4 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Hawaii: open-pipeline peers nationwide
Peers matched on 77 registered trials and 17% open enrollment, not the therapeutic-area sidebar.
University of Hawaii sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 77 trials (± recruiting share)
- U.S. Army Medical Research and Development Command · 77 trials · 4% recruiting
- RAND · 78 trials · 8% recruiting
- Ionis Pharmaceuticals · 76 trials · 12% recruiting
- MetroHealth Medical Center · 76 trials · 13% recruiting
Sponsors near 17% open enrollment (± trial volume)
- Penn State University · 17% recruiting · 219 trials
- University of Utah · 17% recruiting · 818 trials
- CSL Behring · 17% recruiting · 71 trials
- AdventHealth · 17% recruiting · 95 trials
Related
What to do with this University of Hawaii page
77 registered trials is a research-attention snapshot, not an endorsement of University of Hawaii or any single study.
- 13 of University of Hawaii's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Type 2 Diabetes is the condition University of Hawaii studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Type 2 Diabetes trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
University of Hawaii pipeline card: 77 registered trials from official public datasets.Report a data error.